LLY
Eli Lilly and Company · Healthcare · Drug Manufacturers - General
مدخلات الزخم (المديرون المماثلون):
اتساع نطاق المالكين +4.0% ·
تدفق الأسهم +0.6% ·
المراكز الجديدة الصافية +3.8%
— الصيغة
تراكم واسع — ارتفاع الأسهم عبر عدد أكبر من المالكين
جميع أرقام الملكية: مديرو 13F المتتبَّعون فقط، مراكز الأسهم العادية، فترة إعداد التقارير Q4 2024
| الربع | الملّاك | Δ | الأسهم | القيمة المُبلَّغ عنها | جديد | الخروجات |
|---|---|---|---|---|---|---|
| Q2 2026 | 193 | +4 | 671.92M | $804.91B | +6 | −1 |
| Q1 2026 | 191 | -3 | 666.59M | $613.20B | +1 | −5 |
| Q4 2025 | 193 | +2 | 707.04M | $758.81B | +3 | — |
| Q3 2025 | 27 | -3 | 329.88M | $251.63B | +2 | −6 |
| Q2 2025 | 28 | -1 | 307.45M | $239.60B | +2 | −3 |
| Q1 2025 | 26 | 0 | 140.32M | $115.83B | +1 | −1 |
| Q4 2024 | 26 | +1 | 145.00M | $111.91B | +3 | −2 |
| Q3 2024 | 24 | +2 | 109.89M | $97.29B | +2 | — |
| Q2 2024 | 22 | — | 112.43M | $101.75B | — | — |
| # | المدير | الأسهم | Δ الأسهم | القيمة | وزنها | محتفظ به | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (سلبي) | 34.31M | — | $26.49B | 1.0% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 20.86M | -0.3% | $16.11B | 1.9% | ▼ Trim | 3 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 20.86M | -0.3% | $16.11B | 1.9% | ▼ Trim | 3 | SEC ↗ |
| 4 | Capital World Investors ✦ | 19.55M | -4.0% | $15.09B | 2.3% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (سلبي) | 17.38M | +1.7% | $13.39B | 1.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (سلبي) | 17.38M | +1.7% | $13.39B | 1.0% | ▲ Add | 3 | SEC ↗ |
| 7 | PRIMECAP Management ✦ | 16.76M | -5.3% | $12.94B | 10.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 12.63M | +19.0% | $9.75B | 1.8% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 12.63M | +19.0% | $9.75B | 1.8% | ▲ Add | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 12.63M | +19.0% | $9.75B | 1.8% | ▲ Add | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 12.63M | +19.0% | $9.75B | 1.8% | ▲ Add | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 12.63M | +19.0% | $9.75B | 1.8% | ▲ Add | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 12.63M | +19.0% | $9.75B | 1.8% | ▲ Add | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 12.63M | +19.0% | $9.75B | 1.8% | ▲ Add | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 12.63M | +19.0% | $9.75B | 1.8% | ▲ Add | 3 | SEC ↗ |
| 16 | Wellington Management ✦ | 12.63M | +19.0% | $9.75B | 1.8% | ▲ Add | 3 | SEC ↗ |
| 17 | Norges Bank ✦ (سلبي) | 10.89M | +3.9% | $8.41B | 1.1% | ▲ Add | 3 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 5.24M | +3.5% | $4.04B | 1.6% | ▲ Add | 3 | SEC ↗ |
| 19 | Tiger Global Management ✦ | 1.31M | +35.1% | $1.01B | 3.8% | ▲ Add | 3 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 1.24M | +204.1% | $957.87M | 1.1% | ▲ Add | 3 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 1.24M | +204.1% | $957.87M | 1.1% | ▲ Add | 3 | SEC ↗ |
| 22 | Millennium Management ✦ | 801.07K | -19.1% | $618.42M | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 23 | Lone Pine Capital ✦ | 782.86K | جديد | $604.37M | 4.5% | New | 1 | SEC ↗ |
| 24 | Adage Capital Partners ✦ | 732.55K | -11.7% | $565.53M | 1.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 643.94K | -5.0% | $496.17M | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 643.94K | -5.0% | $496.17M | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 643.94K | -5.0% | $496.17M | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 643.94K | -5.0% | $496.17M | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 643.94K | -5.0% | $496.17M | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 643.94K | -5.0% | $496.17M | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 611.27K | +184.1% | $471.90M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 611.27K | +184.1% | $471.90M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 33 | Marshall Wace ✦ | 388.68K | -57.3% | $300.06M | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 34 | Marshall Wace ✦ | 388.68K | -57.3% | $300.06M | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 35 | Marshall Wace ✦ | 388.68K | -57.3% | $300.06M | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 36 | Marshall Wace ✦ | 388.68K | -57.3% | $300.06M | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 37 | Two Sigma Investments ✦ | 322.69K | +61.6% | $249.12M | 0.6% | ▲ Add | 3 | SEC ↗ |
| 38 | Coatue Management ✦ | 213.98K | -13.7% | $165.20M | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 39 | Coatue Management ✦ | 213.98K | -13.7% | $165.20M | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 40 | Coatue Management ✦ | 213.98K | -13.7% | $165.20M | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 41 | Coatue Management ✦ | 213.98K | -13.7% | $165.20M | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 42 | Coatue Management ✦ | 213.98K | -13.7% | $165.20M | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 43 | Bridgewater Associates ✦ | 84.36K | +15.1% | $65.12M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 44 | Duquesne Family Office ✦ | 62.19K | جديد | $48.01M | 1.4% | New | 1 | SEC ↗ |
| 45 | Renaissance Technologies ✦ | 54.12K | -79.0% | $41.78M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 46 | Dodge & Cox ✦ | 44.80K | -0.7% | $34.58M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 47 | Soros Fund Management ✦ | 33.64K | جديد | $25.97M | 0.7% | New | 1 | SEC ↗ |
| 48 | GAMCO Investors ✦ | 33.54K | -3.6% | $25.90M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 49 | Arrowstreet Capital ✦ | 14.85K | -99.1% | $11.46M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 50 | Gotham Asset Management ✦ | 5.78K | -32.1% | $4.46M | 0.0% | ▼ Trim | 3 | SEC ↗ |
"وزنهم" = حصة المركز من إجمالي قيمة حقوق الملكية 13F المُبلَّغ عنها لدى ذلك المدير — مقياس الاقتناع. ✦ = مدير منتقى.
المشترون الجدد
| Lone Pine Capital | $604.37M | 4.5% |
| Duquesne Family Office | $48.01M | 1.4% |
| Soros Fund Management | $25.97M | 0.7% |
تم الخروج
| Viking Global Investors | $134.70M | كان 0.5% |
| Point72 Asset Management | $11.66M | كان 0.0% |
سياق السوق الكاملة: عبر جميع مودعي 13F (بيانات SEC المنظّمة، Q1 2026): 4,323 المالكون, 762.84M الأسهم, $674.93B مُبلَّغ عنه. هذه فترة مختلفة وأقدم من أرقام الكون المتتبع أعلاه، ولا يتم دمج الاثنين في أي وقت.
ما يحمله حاملو هذا الورقة المالية المتتبعون في أغلب الأحيان — إحصاءات التملّك المشترك، لا علاقات أساسية.
مشتريات السوق المفتوحة (P)
لا توجد مشتريات داخلية في السوق المفتوحة ضمن نافذة التغطية لدينا.
مبيعات السوق المفتوحة (S)
Officer · 6.50K سهم · $7.64M
Officer · 2.00K سهم · $2.37M
Officer · 5.00K سهم · $5.95M
لا تُحتسب هنا الجوائز وعمليات التنفيذ والاستقطاع الضريبي ضمن عمليات الشراء أو البيع. المنهجية
The Food and Drug Administration has cleared a new blood test from Roche and Eli Lilly designed to help identify…
ForbesThe Food and Drug Administration cleared a blood test for identifying Alzheimer's disease symptoms, which was developed…
WSJThe U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood test to help identify signs of…
ReutersThe once-daily pill was approved for patients with a body mass index of at least 30, or between 27 and 30 in the event…
WSJEli Lilly said on Monday it has launched its oral pill, Foundayo, in the UK for weight management and type 2…
Reuters